Lexaria Bioscience Receives US Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs …

In one aspect a method of treating a condition is provided wherein a cannabinoid is used to treat conditions selected from the group consisting of cardiac diseases such as heart disease, ischemic infarcts, and cardiometabolic disorders, neurological diseases such as Alzheimer’s disease, Parkinson’s … Read More

The post Lexaria Bioscience Receives US Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs … appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *